Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Warner Chilcott and Watson Pharmaceuticals have announced that under a supply agreement between Warner Chilcott and Watson Pharma, Watson has launched Tilia Fe, the generic version of Warner Chilcott's oral contraceptive Estrostep Fe.
Subscribe to our email newsletter
Under the terms of the agreement, Warner Chilcott will supply Tilia Fe (norethindrone acetate and ethinyl estradiol tablets, and ferrous fumarate tablets) to Watson Pharma, which will market, sell and distribute the generic product in the US.
Warner Chilcott will receive a share of the profits from Watson’s sales of the generic product in the US market.